Lever
Lifestyle
- Regular aerobic exercise
- Weight management
- Smoking cessation
Blutwerte · Marker
sdLDL
Small Dense LDL · Small Dense LDL-Cholesterin · LDL-IVb
Lipide & Herz-KreislaufNüchtern erforderlich
- Einheit:
- mmol/L
sdLDL measures the concentration of small dense low-density lipoprotein particles in the blood.
Reference Ranges
Reference
0.5–1.2mmol/L
0.5
1.2
LowNormalHigh
Reference
Unit · mmol/LReference ranges are not well-established; fasting is typically required.
Overview
Übersicht
Small dense low-density lipoprotein (sdLDL) is a subclass of LDL particles characterized by their smaller size and greater density. Biologically, sdLDL particles are more atherogenic than larger LDL particles due to their ability to penetrate the arterial wall more easily and their susceptibility to oxidation. Researchers have found that sdLDL is a significant biomarker for atherosclerotic cardiovascular disease (ASCVD) risk, as it is more predictive of cardiovascular events than traditional LDL cholesterol measurements. Clinically, elevated levels of sdLDL are associated with an increased risk of coronary artery disease (CAD), metabolic syndrome, and type 2 diabetes. Its measurement can enhance cardiovascular risk assessment beyond conventional lipid profiles. For athletes and biohackers, monitoring sdLDL levels can provide insights into cardiovascular health and the effectiveness of lifestyle interventions aimed at reducing cardiovascular risk. However, the clinical utility of sdLDL in athletic performance and longevity is still under investigation. Caveats include the influence of factors such as triglyceride levels and insulin resistance, which can affect sdLDL concentrations. Fasting before testing is typically required to ensure accurate measurement, and various analytical methods exist, though no gold standard has been established. Researchers recommend considering sdLDL as part of a comprehensive lipid profile for a more nuanced understanding of cardiovascular risk.
Klinische Bedeutung
Elevated sdLDL levels indicate a higher risk of atherosclerotic cardiovascular disease and coronary artery disease. Reduced sdLDL levels are generally considered favorable and indicative of lower cardiovascular risk.
Dynamics
Trend Interpretation
Rising Values
Progressively rising sdLDL values suggest worsening cardiovascular risk. Re-test in 3-6 months if elevated.
Falling Values
Progressively falling sdLDL values suggest improved cardiovascular risk profile.
Re-test Interval
6 months if outside optimal range
Etiology
Causes — High & Low
Cause
Elevated Levels
- Hypertriglyceridemia
- Metabolic syndrome
- Type 2 diabetes
- High carbohydrate diet
- Insulin resistance
Cause
Low Levels
- Low triglyceride levels
- Effective lipid-lowering therapy
- Healthy diet
- Regular physical activity
- Optimal insulin sensitivity
Protocol
How to Optimize
Lever
Nutrition
- Reduce simple carbohydrates
- Increase intake of healthy fats
- Consume more fiber-rich foods
Lever
Supplementation
- Omega-3 fish oil
- Niacin
- Berberine
Note:
Consult a healthcare provider before making significant lifestyle changes, especially if on medication.
Testing Guidelines
🍽️Fasting Required
✓Not Time-Sensitive
Testing Frequency
Annually for individuals at risk of cardiovascular disease.
Interfering Factors
- Recent high-fat meal
- Acute illness
- Medication changes
Open Research Questions
Current research suggests that appropriate clinical reference ranges for small dense LDL cholesterol (sdLDL-C) are needed, as well as optimal targets for its reduction in various populations. Researchers have not yet established the full impact of confounding factors such as triglyceride levels and insulin resistance on sdLDL-C measurements. Additionally, clinical questions remain unanswered regarding the long-term effects of dietary and pharmacological interventions on sdLDL-C levels and their direct correlation with cardiovascular outcomes.
26 Research Publications
753
Total Citations
8
Human/RCT
6.1
Avg. Influence
2025
Latest
Sort
Filter
01Top
#01
Small Dense Low-Density Lipoprotein as Biomarker for Atherosclerotic Diseases.
ReviewInfluence27.0
408
This study reviewed the role of small dense low-density lipoprotein (sdLDL) as a biomarker for atherosclerotic diseases. Researchers found that sdLDL has a greater atherogenic potential than other LDL subfractions and that its measurement can enhance cardiovascular disease prediction.
02Top
#02
Small dense low-density lipoprotein-cholesterol (sdLDL-C): Analysis, effects on cardiovascular endpoints and dietary strategies.
ReviewInfluence1.0
84
This literature review discussed the significance of small dense low-density lipoprotein cholesterol (sdLDL-C) as a biomarker for cardiovascular disease. Researchers observed that sdLDL-C is associated with various cardiovascular ailments and that certain dietary choices can help manage sdLDL-C levels. Additionally, pharmacological agents were identified that effectively lower sdLDL-C concentrations.
03Top
#03
Small dense low-density lipoprotein: Analytical review.
ReviewInfluence7.0
67
This analytical review examined methods for measuring small dense low-density lipoprotein (sdLDL). Researchers found that while various techniques exist, there is no gold standard for sdLDL measurement, and most methods remain confined to research settings due to their complexity and validation issues.
04
#04
Small dense low-density lipoprotein particles: clinically relevant?
ReviewInfluence4.0
49
This review focused on the clinical relevance of small dense low-density lipoprotein (sdLDL) particles in cardiovascular disease risk. Researchers observed that higher sdLDL levels are significantly associated with increased atherosclerotic cardiovascular disease risk, independent of other lipid factors.
05
#05
Update on the laboratory investigation of dyslipidemias.
Review
40
This review examined the evolving role of clinical laboratories in assessing cardiovascular disease risk through lipid measurements. Researchers pointed out that current methods for measuring LDL cholesterol have limitations and suggested that measuring LDL particle size and concentration could provide better risk predictions. The review calls for robust methods to evaluate lipoprotein subclasses and their role in cardiovascular risk assessment.
06
#06
The clinical significance of the size of low-density-lipoproteins and the modulation of subclasses by fibrates.
ReviewInfluence2.0
31
This study reviewed the impact of LDL size on cardiovascular risk and the effects of fibrate treatments on LDL subclasses. Researchers found that fibrates can beneficially modulate LDL size, particularly fenofibrate, which was noted to be effective in patients at higher cardiovascular risk. The findings support the importance of LDL quality in cardiovascular risk management.
07
#07
Clinical significance of small dense low-density lipoprotein cholesterol measurement in type 2 diabetes.
ReviewInfluence1.0
22
This review focused on the clinical significance of small dense low-density lipoprotein cholesterol (sdLDL-C) in patients with type 2 diabetes. Researchers observed that sdLDL-C is a better predictor of atherosclerotic cardiovascular disease (ASCVD) than traditional LDL-C measurements. The study emphasized the importance of sdLDL-C in understanding metabolic dysfunction and its association with various complications.
08
#08
Association of LDL-cholesterol subfractions with cardiovascular disorders: a systematic review.
Meta-Analysis
21
This systematic review evaluated the association between low-density lipoprotein (LDL) subfractions and cardiovascular disorders. Researchers concluded that higher LDL particle numbers, particularly small dense LDL, are consistently linked to increased cardiovascular disease risk. The review suggests that assessing LDL subclasses may serve as a valuable biomarker for cardiovascular disease diagnosis.
09
#09
Estimated Small, Dense LDL Cholesterol and Atherosclerotic Cardiovascular Risk in the UK Biobank.
Zubiran Rafael, et al. · Arteriosclerosis, thrombosis, and vascular biology · 2025
Human
12
This study examined the role of estimated small, dense low-density lipoprotein cholesterol (E-sdLDL-C) in assessing cardiovascular disease risk. Researchers found that E-sdLDL-C was significantly associated with atherosclerotic cardiovascular disease events, outperforming traditional LDL cholesterol measurements. Additionally, when E-sdLDL-C levels were higher than other lipid markers, the risk for cardiovascular events increased further.
Key findings
- 01E-sdLDL-C is strongly associated with the risk of developing atherosclerotic cardiovascular disease (ASCVD).
- 02When E-sdLDL-C levels are higher than standard LDL cholesterol or apolipoprotein B, the risk for ASCVD increases significantly.
- 03E-sdLDL-C provides a more accurate risk assessment for heart disease compared to traditional LDL cholesterol measurements.
10
#10
Atherogenic low-density lipoprotein and cardiovascular risk.
Review
7
This review highlighted the residual cardiovascular risk associated with low-density lipoprotein (LDL) despite cholesterol level reductions. Researchers found that small dense LDL is linked to increased cardiovascular disease risk and emphasized the need for comprehensive profiling of LDL particles for better risk assessment.
Publication Trend
Research publications about sdLDL over time
10totalTrack your bloodwork in PepStack
Log lab results, track trends and optimize your biomarkers over time.
Legal Disclaimer
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer